PAPIVAX BIOTECH INCORPORATED
Area: Government, Academia and Research Institutes
Booth No: N406
Website: https://papivax.com/zh/
Exhibitor Profile
PBI was established in 2013 and is located in the National Biotechnology Research Park. It is a company specializing in the development of DNA vaccine technology platforms and is dedicated to eradicating cancers caused by human papillomavirus (HPV) infection, with the goal of becoming a global leader in DNA immunotherapy. Currently, we have three treatments targeting cervical cancer and head and neck cancer caused by HPV, achieving remarkable results in clinical trials.
Brands
The leader in nucleic acid drug immunotherapy
Exhibit Products
Exhibitor Press Release
Exhibitors you may be interested in
Highest Rated